JP2024512978A5 - - Google Patents

Info

Publication number
JP2024512978A5
JP2024512978A5 JP2023559686A JP2023559686A JP2024512978A5 JP 2024512978 A5 JP2024512978 A5 JP 2024512978A5 JP 2023559686 A JP2023559686 A JP 2023559686A JP 2023559686 A JP2023559686 A JP 2023559686A JP 2024512978 A5 JP2024512978 A5 JP 2024512978A5
Authority
JP
Japan
Prior art keywords
composition
immune cell
container
cell population
additive composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023559686A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512978A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2022/004509 external-priority patent/WO2022211491A1/ko
Publication of JP2024512978A publication Critical patent/JP2024512978A/ja
Publication of JP2024512978A5 publication Critical patent/JP2024512978A5/ja
Pending legal-status Critical Current

Links

JP2023559686A 2021-03-30 2022-03-30 免疫細胞組成物を生成するための方法 Pending JP2024512978A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2021-0040926 2021-03-30
KR20210040926 2021-03-30
PCT/KR2022/004509 WO2022211491A1 (ko) 2021-03-30 2022-03-30 면역세포 조성물을 생산하는 방법

Publications (2)

Publication Number Publication Date
JP2024512978A JP2024512978A (ja) 2024-03-21
JP2024512978A5 true JP2024512978A5 (cg-RX-API-DMAC7.html) 2025-04-03

Family

ID=83459472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023559686A Pending JP2024512978A (ja) 2021-03-30 2022-03-30 免疫細胞組成物を生成するための方法

Country Status (5)

Country Link
US (1) US20240181053A1 (cg-RX-API-DMAC7.html)
EP (1) EP4317423B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024512978A (cg-RX-API-DMAC7.html)
KR (2) KR102666931B1 (cg-RX-API-DMAC7.html)
WO (1) WO2022211491A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1029719B1 (fr) * 2021-08-27 2023-03-27 Fyteko Sa Combinaison à activité herbicide pour des applications agricoles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120244133A1 (en) * 2011-03-22 2012-09-27 The United States of America, as represented by the Secretary, Department of Health and Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
JOP20190224A1 (ar) * 2017-03-29 2019-09-26 Iovance Biotherapeutics Inc عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
WO2019136459A1 (en) * 2018-01-08 2019-07-11 Iovance Biotherapeutics, Inc. Processes for generating til products enriched for tumor antigen-specific t-cells
EA202092319A1 (ru) * 2018-03-29 2021-03-04 Айовэнс Байотерапьютикс, Инк. Способы получения опухоль-инфильтрирующих лимфоцитов и применения их в иммунотерапии
WO2019210131A1 (en) * 2018-04-27 2019-10-31 Iovance Biotherapeutics, Inc. Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
WO2019217753A1 (en) * 2018-05-10 2019-11-14 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
CA3118493A1 (en) * 2018-11-05 2020-05-14 Iovance Biotherapeutics, Inc. Expansion of tils utilizing akt pathway inhibitors
KR20200092155A (ko) * 2019-01-24 2020-08-03 울산대학교 산학협력단 종양침윤림프구를 유효성분으로 포함하는 삼중음성 유방암 예방 또는 치료용 조성물
WO2020232029A1 (en) * 2019-05-13 2020-11-19 Iovance Biotherapeutics, Inc. Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
CN110938594A (zh) * 2019-09-12 2020-03-31 夏建川 一种功能增强型til细胞的培养方法

Similar Documents

Publication Publication Date Title
US20230000919A1 (en) Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US20230323298A1 (en) Gammadelta t cell expansion procedure
Klapper et al. Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy
JP2021503281A5 (cg-RX-API-DMAC7.html)
CN115369086B (zh) 一种nk细胞扩大培养的培养方案
CN108624559B (zh) 无饲养层体外扩增原代nk细胞的培养组合物及其应用
JP2020515257A5 (cg-RX-API-DMAC7.html)
Albrecht et al. Generation of colon cancer–derived tumor-infiltrating T cells (TILs) for adoptive cell therapy
CN104789527A (zh) 一种自体自然杀伤细胞鸡尾酒式培养的制备方法及其试剂盒产品
CN115558641B (zh) 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用
JP2023523429A5 (cg-RX-API-DMAC7.html)
CN109337870A (zh) 人Vγ9Vδ2T细胞扩增方法与培养基
CN116240168A (zh) Nk细胞的制备及其应用
IL293874B2 (en) Improved process for culturing tumor-infiltrating lymphocytes for therapeutic use
EP2878666A1 (en) Industrial preparation of natural killer cells (nks) and injection using human allogeneic karyocytes
Shimizu et al. Clonal analysis of tumor‐infiltrating lymphocytes from human primary and metastatic liver tumors
Stroncek et al. Developments in clinical cell therapy
CN108456658A (zh) 促进造血干细胞扩增并抑制其分化的化合物及细胞因子组合物
US20230295566A1 (en) Method for producing tumor-infiltrating t-lymphocytes (til) and their use as cellular therapeutics for the treatment of human tumors
Wang et al. Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo
WO2023078427A1 (zh) 一种体外大规模扩增富含Tscm和Tcm的双阴性T细胞的方法
CN117427158A (zh) 奈非那韦联合免疫检查点抑制剂在制备抗肿瘤药物中的应用
CN116458494A (zh) 一种高纯度nk细胞库构建方法
CN103160464A (zh) 一种快速增殖效应淋巴细胞的制备方法及其试剂盒、用途
CN118726252B (zh) 免疫细胞培养基和免疫细胞的培养方法